Assessment of Physical Stability of an Antibody Drug Conjugate by Higher Order Structure Analysis: Impact of Thiol- Maleimide Chemistry
暂无分享,去创建一个
Sandeep Kumar | Jianxin Guo | Satish K. Singh | Sandeep Kumar | S. Singh | Jason A. Starkey | Jason Starkey | Amarnauth Prashad | Jian-xin Guo | Jianxin Guo | A. Prashad | Satishwer Singh | Amar S. Prashad
[1] Linda O Narhi,et al. High throughput thermostability screening of monoclonal antibody formulations. , 2010, Journal of pharmaceutical sciences.
[2] Joseph McGuire,et al. Molecular origins of surfactant-mediated stabilization of protein drugs. , 2011, Advanced drug delivery reviews.
[3] M. Haidekker,et al. Effects of solvent polarity and solvent viscosity on the fluorescent properties of molecular rotors and related probes. , 2005, Bioorganic chemistry.
[4] Bernhardt L Trout,et al. Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding , 2011, mAbs.
[5] J. Ralston,et al. Solution Behavior of IFN-β-1a: An Empirical Phase Diagram Based Approach , 2005 .
[6] Anna M Wu,et al. Arming antibodies: prospects and challenges for immunoconjugates , 2005, Nature Biotechnology.
[7] Colleen E. Price,et al. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[8] Aditya A Wakankar,et al. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. , 2010, Bioconjugate chemistry.
[9] C. Roberts,et al. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. , 2011, Journal of pharmaceutical sciences.
[10] Mark A Haidekker,et al. Environment-sensitive behavior of fluorescent molecular rotors , 2010, Journal of biological engineering.
[11] Bernhardt L Trout,et al. Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. , 2011, Journal of pharmaceutical sciences.
[12] C Russell Middaugh,et al. Stability of helix-rich proteins at high concentrations. , 2006, Biochemistry.
[13] Damon L. Meyer,et al. Contribution of linker stability to the activities of anticancer immunoconjugates. , 2008, Bioconjugate chemistry.
[14] C Russell Middaugh,et al. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study. , 2003, Journal of pharmaceutical sciences.
[15] C E Kung,et al. Fluorescent molecular rotors: a new class of probes for tubulin structure and assembly. , 1989, Biochemistry.
[16] Michael M C Sun,et al. Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides. , 2005, Bioconjugate chemistry.
[17] K. Kiick,et al. Tunable degradation of maleimide-thiol adducts in reducing environments. , 2011, Bioconjugate chemistry.
[18] John F. Carpenter,et al. Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.
[19] Christopher J Roberts,et al. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies. , 2010, Journal of pharmaceutical sciences.
[20] Akihisa Nonoyama,et al. A biophysical characterization of the peptide drug pramlintide (AC137) using empirical phase diagrams. , 2008, Journal of pharmaceutical sciences.
[21] Damon L. Meyer,et al. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.
[22] M C Manning,et al. Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. , 1999, Biochemistry.
[23] Garrett M. Morris,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.
[24] Tim J Kamerzell,et al. Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability. , 2009, Journal of pharmaceutical sciences.
[25] M. Lindgren,et al. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. , 2005, Biophysical journal.
[26] Robert A. Grothe,et al. Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.
[27] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[28] Boyan Zhang,et al. Identification of amino acid residues responsible for the release of free drug from an antibody-drug conjugate utilizing lysine-succinimidyl ester chemistry. , 2011, Journal of pharmaceutical sciences.
[29] Heather T. McFarlane,et al. Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.
[30] Heather Franey,et al. Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates , 2010, Protein science : a publication of the Protein Society.
[31] Bernhardt L Trout,et al. Computational methods to predict therapeutic protein aggregation. , 2012, Methods in molecular biology.
[32] Bruce D Mason,et al. Opalescence of an IgG2 monoclonal antibody solution as it relates to liquid-liquid phase separation. , 2011, Journal of pharmaceutical sciences.
[33] Aditya A Wakankar,et al. Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.
[34] R. Chari. Targeted cancer therapy: conferring specificity to cytotoxic drugs. , 2008, Accounts of chemical research.
[35] David Eisenberg,et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.
[36] Vasco Filipe,et al. Fluorescent Molecular Rotors as Dyes to Characterize Polysorbate-Containing IgG Formulations , 2009, Pharmaceutical Research.
[37] S. Joshi,et al. Investigation of protein conformational stability employing a multimodal spectrometer. , 2011, Analytical chemistry.